LONDON: – Britain’s King Charles will return to public duties next week for the first time since being diagnosed with cancer as he makes good progress following treatment and a period of recuperation, Buckingham Palace said on Friday.
In February, the palace revealed that the 75-year-old king had been diagnosed with an unspecified form of cancer detected in tests after a corrective procedure for an enlarged prostate.
Watch: King Charles prepares to return to public duties after reacting positively to cancer treatment pic.twitter.com/eCgxloL383
— The Independent (@Independent) April 26, 2024
Although Charles continued with official state business, the diagnosis led him to postpone public engagements to begin treatment and rest.
“His majesty’s treatment programme will continue, but doctors are sufficiently pleased with the progress made so far that the king is now able to resume a number of public-facing duties,” a Buckingham Palace spokesperson said. “His majesty is greatly encouraged to be resuming some public-facing duties and very grateful to his medical team for their continued care and expertise.”
Although it was too early to say how much longer his cancer treatment would last, the spokesperson said his doctors were “very encouraged by the progress made so far and remain positive about the king’s continued recovery”.
No further details about his condition or his treatment were given, in line with the usual stance on medical privacy.
While pictured and filmed carrying out some official duties in private, Charles’s only public appearance came last month when he greeted well-wishers in an impromptu walkabout after an Easter church service in Windsor, raising hopes that his health was improving.
British Prime Minister Rishi Sunak responded to the news of the king’s return to public duties, saying on social media site X: “Brilliant news to end the week!”
Brilliant news to end the week! https://t.co/icGXxS0TUB
— Rishi Sunak (@RishiSunak) April 26, 2024
To mark his return, Charles and his wife Queen Camilla will visit a cancer treatment centre in London next Tuesday, the palace said. It was also confirmed that the Japanese Emperor Naruhito and his wife, Empress Masako, would pay a state visit in late June.
However, Charles will not carry out his usual summer programme and his plans will be crafted in consultation with his medical team to minimise risks to recovery, the palace said.
The king’s absence has coincided with news that his daughter-in-law Kate, wife of his son and heir Prince William, was undergoing preventative chemotherapy after tests in the wake of major abdominal surgery revealed cancer had been present.
The Princess of Wales, often known by her maiden name Kate Middleton, will herself only return to public duties when her medical team say she is well enough to do so.
Charles’s health scare came less than 18 months into his reign after he succeeded from his mother, the late Queen Elizabeth, and less than a year since his coronation, Britain’s biggest ceremonial event for seven decades.
“As the first anniversary of the coronation approaches, their majesties remain deeply grateful for the many kindnesses and good wishes they have received from around the world throughout the joys and challenges of the past year,” Buckingham Palace said.
(REUTERS)
In a career spanning three decades and counting, Ramananda (Ram to his friends) has been the foreign editor of The Telegraph, Outlook Magazine and the New Indian Express. He helped set up rediff.com’s editorial operations in San Jose and New York, helmed sify.com, and was the founder editor of India.com.
His work has featured in national and international publications like the Al Jazeera Centre for Studies, Global Times and Ashahi Shimbun. But his one constant over all these years, he says, has been the attempt to understand rising India’s place in the world.
He can rustle up a mean salad, his oil-less pepper chicken is to die for, and all it takes is some beer and rhythm and blues to rock his soul.
Talk to him about foreign and strategic affairs, media, South Asia, China, and of course India.
